Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)
Top Cited Papers
- 1 September 2005
- journal article
- Published by Elsevier in The Lancet
- Vol. 366 (9489) , 907-913
- https://doi.org/10.1016/s0140-6736(05)67186-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke PreventionHypertension, 2005
- Vascular Development, Pulse Pressure, and the Mechanisms of HypertensionHypertension, 2005
- VALUE: analysis of resultsThe Lancet, 2004
- Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe TrialJournal Of Hypertension, 2004
- Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialThe Lancet, 2003
- Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesThe Lancet, 2002
- Blood-pressure reduction and cardiovascular risk in HOPE studyThe Lancet, 2001
- Body-Mass Index and Mortality in a Prospective Cohort of U.S. AdultsNew England Journal of Medicine, 1999
- Prospective Randomized Open Blinded End-point (PROBE) Study. A novel design for intervention trialsBlood Pressure, 1992
- Diuretics, serum potassium and ventricular arrhythmias in the Multiple Risk Factor Intervention TrialThe American Journal of Cardiology, 1987